Skip to main content

Back on Lovenox

I started the new blood thinner 3 weeks ago. Within the last week, I noticed that I was losing copious amounts of hair. It is distressing to see a huge pile of hair come out after showering and combing my hair. I have extremely thick hair, so much so that hair stylists occasionally thin it. It probably looks normal to everyone else, but I feel like I've probably lost at least 10% of my hair--much more than when I've gotten it thinned. 😭

It turns out hair loss is a common side effect of some blood thinners. I didn't have this problem with Lovenox or Eliquis, so I had no idea to be on the lookout for it. After consulting with my hematologist, I am back on two shots a day of Lovenox. He thought it was too risky to try Eliquis again (I took this pill last year, and a month later I was back in the hospital with recurring blood clots). 

It is very disappointing to go back on Lovenox, but I can handle the 2 shots a day. I'm more distressed about how much longer I'm going to be losing hair. One of my Tagrisso side effects is that my hair grows very slowly, so it will be ages before I get my full head of hair back. 😞 

The big picture is that my lung function has improved, and I'm tremendously grateful for that. But this latest problem just feels like One. More. Thing.

~~~~

In happier news, my undergrad class met for the last time on Friday. (This was the first undergrad class I've taught at PSU.) During our reflection time, a student who's a junior said it was the most useful class he's ever taken, and a bunch of other students chimed in with agreement. It was my first time teaching this course (writing, public speaking, study skills, learning about university resources), so that was very gratifying.


Comments

Popular posts from this blog

regular update

I had my regular oncology appointment in Pittsburgh yesterday. Dr. Villaruz said the scans look good and everything is stable. Although I don’t have much scanxiety nowadays, it’s always a relief to get good news. Just to be sure that my understanding was correct, I asked her why I’m not a candidate for surgery. It’s because of the cancer’s growth pattern. The one nodule that’s visible on the CT scan could just be scarring; she’s not sure if it’s a tumor. When I was diagnosed, I was told the lung cancer was “lepidic.” This means that the tumor cells were growing along the lining of the alveolar structures (air sacs).* That’s why my lungs looked like they were draped in cobwebs. You can’t do surgery in enough places to get all of it. Thankfully, Tagrisso swept out those cobwebs – and continues to do so. We go back in December for a regular appointment. *Lepidic spread tends to be slow-growing, with minimal invasion of nearby tissues, less chance of metastasis, and overall better progno...

38.6 months

September 18 marked 38.6 months (3 years, 2 months, 18 days) since I first started taking Tagrisso. Why is 38.6 months significant? Because it is the median overall survival in the FLAURA study, a landmark study (2014-16) comparing Tagrisso and older targeted therapies among patients with advanced non-small cell lung cancer, EGFR mutation, and no prior treatment. 279 patients received Tagrisso and 277 people received an older drug (in addition, all patients received at least one dose of a trial drug). Nearly 58% of patients had died when data collection stopped. However, patients in the Tagrisso group lived nearly 7 months longer (median) than the control group. When Leland and I initially read that number – 38.6 months – in the Tagrisso promotional materials, we were stunned. This was supposed to be good news? The median age in the FLAURA study was 64 and at the time (August 2022), I had just turned 50. But still, it was a sobering statistic. For the longest time, I didn't feel ...

A failure of institutional care

I just hit "send" on this letter to my dean and associate dean. Mic drop. I've never sent such a scathing letter, but it's definitely called for in this situation. I'm not expecting anything other than a "Oh, that wasn't how we intended to make you feel; our hands were tied" email. Dear Dean Lawless and Associate Dean Lloyd, When I wrote to Professor Land [my department head] to see if I could get a course release this fall due to having lung cancer plus complications from pulmonary embolism and COVID, I had no idea what I was in for. When faculty friends in other colleges have had health crises (ones that don’t warrant a full-semester medical leave), their department head or dean has simply said, “Don’t worry about teaching this semester. We’ll figure it out.” I figured the same would happen in my case. To be blunt, the way that my case was handled was a colossal failure of leadership. As my husband and I have shared my story with colleagues at PSU ...